Standard

Phospholipids to total lipids ratio in large LDL

CHLSN · rs869412

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−15, with 5 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.0372 lower (95% confidence interval 0.028-0.046); p = 2 × 10−15.

How common The T allele had a frequency of about 77% in the people studied.

Where it sits Chromosome 7, band 7p22.3 — in an intron of CHLSN.

How common each version is

CT
Korean KRGDB
C 24.6% · T 75.4%
Korean Korea4K
C 24.4% · T 75.6%
Korean Korea1K
C 24.6% · T 75.4%
Japanese ToMMo
C 27.9% · T 72.1%
Vietnamese
C 12.0% · T 88.0%
World gnomAD
C 17.6% · T 82.4%
World 1000 Genomes
C 16.0% · T 84.0%
World TOPMed
C 16.9% · T 83.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

C/C No copy of the version the research linked to Phospholipids to total lipids ratio in large LDL. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Phospholipids to total lipids ratio in large LDL. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Phospholipids to total lipids ratio in large LDL. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Questions about rs869412

What is rs869412?

rs869412 is a single position in the genome, in or near the CHLSN gene. Published research associates it with phospholipids to total lipids ratio in large ldl. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs869412 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs869412 come from?

GWAS Catalog, Nature 2024, PMID:38448586. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Phospholipids to total lipids ratio in large LDL (rs869412). MyGeneLog™. https://www.mygenelog.com/variants/rs869412

← See all variants